Latest In McKesson
Year-to-dates sales increased 10 percent year-over-year.
Acquisition includes UDGs pharmaceutical distribution, home health care and travel health care divisions.
Distribution Solutions sales grew 37 percent in the quarter for McKesson.
McKesson Specialty Health expands cancer care support with acquisition.
McKesson will exceed the 75% ownership threshold of Celesio through agreements to purchase shares and bonds from two entities.
Drug distributor failed to reach the 75% completion condition for outstanding shares of Celesio.
MSC's acquisition of Barnes' North American distribution operations was among the top deals in 2013.
The company was renamed Aesynt upon closing.
To access this page, you must purchase MDM Premium Subscription, MDM Premium Subscription – Monthly or MDM Premium Subscription – Annually.
Distribution Solutions sales grew 11 percent in the quarter for McKesson.
To access this page, you must purchase MDM Premium Subscription, MDM Premium Subscription – Monthly or MDM Premium Subscription – Annually.
Deal expands McKesson’s reach to Europe and results in a more than $150B company.
To access this page, you must purchase MDM Premium Subscription, MDM Premium Subscription – Monthly or MDM Premium Subscription – Annually.
Profit increased 7.6 percent to $424 million.
To access this page, you must purchase MDM Premium Subscription, MDM Premium Subscription – Monthly or MDM Premium Subscription – Annually.
Distribution Solutions sales were flat for the full year compared to the prior year.
To access this page, you must purchase MDM Premium Subscription, MDM Premium Subscription – Monthly or MDM Premium Subscription – Annually.
Profit decreased 0.7 percent from prior-year levels.
To access this page, you must purchase MDM Premium Subscription, MDM Premium Subscription – Monthly or MDM Premium Subscription – Annually.
